Geneos Wealth Management Inc. Takeda Pharmaceutical CO LTD Transaction History
Geneos Wealth Management Inc.
- $2.77 Billion
- Q4 2024
A detailed history of Geneos Wealth Management Inc. transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 1,219 shares of TAK stock, worth $16,493. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,219
Previous 1,891
35.54%
Holding current value
$16,493
Previous $26,000
38.46%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding TAK
# of Institutions
333Shares Held
73.3MCall Options Held
1.96MPut Options Held
165K-
Capital Research Global Investors Los Angeles, CA13.1MShares$178 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.35MShares$72.5 Million0.01% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA4.64MShares$62.7 Million0.05% of portfolio
-
Goldman Sachs Group Inc New York, NY4.56MShares$61.7 Million0.01% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.41MShares$46.1 Million0.02% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $42.1B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...